Clinical Trial Update: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update for nasal glucagon (LY900018) in Japanese participants with diabetes mellitus, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Nasal glucagon (LY900018) (LY900018)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-10-08